TRAF2 and malignant colon neoplasm: A dominant oncogenic driver of colon cancer development is the Wnt/β-catenin signaling pathway culminating in the formation and activation of a nuclear transcriptional complex containing β-catenin, T-cell factor 4 (TCF4) and the TRAF2- and Nck-interacting kinase (TNIK).